Abstract
At the request of authors, the following article has been removed:
Ye K, Yu C, Shen Z. Severe refractory colitis after intraperitoneal infusion of CEA-directed CAR T cells in patients with colorectal cancer. Therapeutic Advances in Medical Oncology. 2024;16. doi:10.1177/17588359241309825
Due to the involvement of patient data from the clinical trial associated with the case report, the Principal Investigator (PI) of the clinical trial contacted the author to advise them that publication of the clinical trial results must precede the publication of this case report. Given this requirement, the authors would like to request the withdrawal of their case report from the current issue, and plan to re-submit it for potential publication once the clinical trial results have been published.